#ITI#Potency of a recombinant NDV-H5 vaccine against various HPAI H5N1 virus challenges in SPF chickens#FTI#
#IRE#For the past decade, several recombinant Newcastle disease viruses (rNDV) have been used as a vector to express native or modified avian influenza (AI) hemagglutinins (HA) in order to give preventive protection against highly pathogenic avian influenza (HPAI) H5N1 viruses. Obtained protections were dependent on the age of the chickens, on the constructs and, in particular, on the homology between the HA that was inserted and the challenge strains. The objective of this study was to investigate the vaccine efficacy of a recombinant NDV La Sota-vectored vaccine expressing an Asian clade 1 H5 ectodomain (rNDV-H5) vaccine expressing a modified H5 ectodomain from an HPAI clade 1 H5N1 isolate as vaccine for 1-day-old specific-pathogen-free chickens. The inoculation route (oculonasal vs. drinking water), the dose-effect, and the protective range of this rNDV-H5 vaccine were studied. Both routes of vaccination induced an H5 serologic response and afforded a high degree of clinical protection against an Asian clade 1 HPAI H5N1 (AsH5N1) challenge without a significant difference between inoculation routes. A clear dose-effect could be demonstrated. Furthermore, when evaluating the protective range against antigenically divergent descendants of the Asian clade 1 HPAI H5N1 lineage, namely two Egyptian clade 2.2.1 H5N1 strains, the vaccine efficacy was less satisfactory. The rNDV-H5 vaccine provided good clinical protection and reduced viral shedding against Egyptian 2007 challenge but was unable to provide a similar protection against the more antigenically divergent Egyptian 2008 strain.#FRE#
#IPC#HPAI H5N1; rNDV-H5; SPF chicken; vaccination#FPC#
#IRF#Alexander D.J., Senne D.A., Newcastle disease, other avian paramyxoviruses and pneumoviruses, Diseases of Poultry, pp. 75-100, (2008); 
Brown I.H., Summary of avian influenza activity in Europe Asia and Africa 2006-2009, Avian Dis, 54, pp. 187-193, (2010); 
Cattoli G., Milani A., Temperton N., Zecchin B., Buratin A., Molesti E., Aly M.M., Arafa A., Capua I., Antigenic drift in H5N1 avian influenza virus in poultry is driven by mutations in major antigenic sites of the hemagglutinin molecule analogous to those for human influenza virus, J. Virol, 85, pp. 8718-8724, (2011); 
Czifra G., Meszaros J., Horvath E., Moving V., Engstrom B.E., Detection of NDV-specific antibodies and the level of protection provided by a single vaccination in young chickens, Avian Pathology, 27, 6, pp. 562-565, (1998); 
DiNapoli J.M., Kotelkin A., Yang L., Elankumaran S., Murphy B.R., Samal S.K., Collins P.L., Bukreyev A., Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens, Proceedings of the National Academy of Sciences of the United States of America, 104, 23, pp. 9788-9793, (2007); 
Dinapoli J.M., Nayak B., Yang L., Finneyfrock B.W., Cook A., Andersen H., Torres-Velez F., Murphy B.R., Samal S.K., Collins P.L., Bukreyev A., Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys, J. Virol, 84, pp. 1489-1503, (2010); 
Ellebedy A.H., Webby R.J., Influenza vaccines, Vaccine, 27, SUPPL. 4, (2009); 
Ge J., Deng G., Wen Z., Tian G., Wang Y., Shi J., Wang X., Li Y., Hu S., Jiang Y., Yang C., Yu K., Bu Z., Chen H., Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses, Journal of Virology, 81, 1, pp. 150-158, (2007); 
Ge J., Wang X., Tao L., Wen Z., Feng N., Yang S., Xia X., Yang C., Chen H., Bu Z., Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats, J. Virol, 85, pp. 8241-8252, (2011); 
Huang Z., Elankumaran S., Yunus A.S., Samal S.K., A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV, Journal of Virology, 78, 18, pp. 10054-10063, (2004); 
Mast J., Goddeeris B.M., Development of immunocompetence of broiler chickens, Veterinary Immunology and Immunopathology, 70, 3-4, pp. 245-256, (1999); 
Nakaya T., Cros J., Park M.-S., Nakaya Y., Zheng H., Sagrera A., Villar E., Garcia-Sastre A., Palese P., Recombinant newcastle disease virus as a vaccine vector, Journal of Virology, 75, 23, pp. 11868-11873, (2001); 
Nayak B., Rout S.N., Kumar S., Khalil M.S., Fouda M.M., Ahmed L.E., Earhart K.C., Perez D.R., Collins P.L., Samal S.K., Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses, PLoS One, 4, (2009); 
Chapter 2.3.4. Avian influenza, Manuals of Diagnostic Tests and Vaccines for Terrestrials Animals, (2011); 
Park M.-S., Steel J., Garcia-Sastre A., Swayne D., Palese P., Engineered viral vaccine constructs with dual specificity: Avian influenza and Newcastle disease, Proceedings of the National Academy of Sciences of the United States of America, 103, 21, pp. 8203-8208, (2006); 
Peyre M., Fusheng G., Desvaux S., Roger F., Avian influenza vaccines: A practical review in relation to their application in the field with a focus on the Asian experience, Epidemiol. Infect, 137, pp. 1-21, (2009); 
Peyre M., Samaha H., Makonnen Y.J., Saad A., Abd-Elnabi A., Galal S., Ettel T., Dauphin G., Lubroth J., Roger F., Domenech J., Avian influenza vaccination in Egypt: Limitations of the current strategy, J. Mol. Genet. Med, 3, pp. 198-204, (2009); 
Ramp K., Veits J., Deckers D., Rudolf M., Grund C., Mettenleiter T.C., Romer-Oberdorfer A., Coexpression of avian influenza virus H5 and N1 by recombinant Newcastle disease virus and the impact on immune response in chickens, Avian Dis, 55, pp. 413-421, (2011); 
Rauw F., Palya V., Van Borm S., Welby S., Tatar-Kis T., Gardin Y., Dorsey K.M., Aly M.M., Hassan M.K., Soliman M.A., Van Den Berg T., Lambrecht B., Further evidence of antigenic drift and protective efficacy afforded by a recombinant HVT-H5 vaccine against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains, Vaccine, 29, pp. 2590-2600, (2011); 
Reid S.M., Shell W.M., Barboi G., Onita I., Turcitu M., Cioranu R., Marinova-Petkova A., Goujgoulova G., Webby R.J., Webster R.G., Russell C., Slomka M.J., Hanna A., Banks J., Alton B., Barrass L., Irvine R.M., Brown I.H., First reported incursion of highly pathogenic notifiable avian influenza A H5N1 viruses from clade 2.3.2 into European poultry, Transbound. Emerg. Dis, 58, pp. 76-78, (2011); 
Sarfati-Mizrahi D., Lozano-Dubernard B., Soto-Priante E., Castro-Peralta F., Flores-Castro R., Loza-Rubio E., Gay-Gutierrez M., Protective dose of a recombinant Newcastle disease LaSota-avian influenza virus H5 vaccine against H5N2 highly pathogenic avian influenza virus and velogenic viscerotropic Newcastle disease virus in broilers with high maternal antibody levels, Avian Dis, 54, pp. 239-241; 
Senne D.A., King D.J., Kapczynski D.R., Control of newcastle disease by vaccination, Developments in Biologicals, 119, pp. 165-170, (2005); 
Spackman E., Senne D.A., Bulaga L.L., Trock S., Suarez D.L., Development of multiplex real-time RT-PCR as a diagnostic tool for avian influenza, Avian Diseases, 47, SPEC. ISS., pp. 1087-1090, (2003); 
Spackman E., Senne D.A., Myers T.J., Bulaga L.L., Garber L.P., Perdue M.L., Lohman K., Daum L.T., Suarez D.L., Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes, Journal of Clinical Microbiology, 40, 9, pp. 3256-3260, (2002); 
Steensels M., Van Borm S., Boschmans M., Van Den Berg T., Lethality and molecular characterization of an HPAI H5N1 virus isolated from eagles smuggled from Thailand into Europe, Avian Diseases, 51, SUPPL. 1, pp. 401-407, (2007); 
Suetens C.S., Hanquet R., Brochier G., Maes B., Thomas S., Yane I.F., Berg Den T.Van, Van Borm S., Eagles testing positive for H5N1 imported illegally into Europe from Thailand, Eurosurveillance, 8, (2004); 
Swayne D.E., Principles for vaccine protection in chickens and domestic waterfowl against avian influenza: Emphasis on Asian H5N1 high pathogenicity avian influenza, Annals of the New York Academy of Sciences, 1081, pp. 174-181, (2006); 
Swayne D.E., Suarez D.L., Schultz-Cherry S., Tumpey T.M., King D.J., Nakaya T., Palese P., Garcia-Sastre A., Recombinant paramyxovirus type 1-avian influenza-H7 virus as a vaccine for protection of chickens against influenza and Newcastle disease, Avian Diseases, 47, SPEC. ISS., pp. 1047-1050, (2003); 
Van Borm S., Steensels M., Ferreira H.L., Boschmans M., De Vriese J., Lambrecht B., Van Den Berg T., A universal avian endogenous real-time reverse transcriptase-polymerase chain reaction control and its application to avian influenza diagnosis and quantification, Avian Diseases, 51, SUPPL. 1, pp. 213-220, (2007); 
Van Borm S., Thomas I., Hanquet G., Lambrecht B., Boschmans M., Dupont G., Decaestecker M., Snacken R., Van Den Berg T., Highly pathogenic H5N1 influenza virus in smuggled Thai eagles, Belgium, Emerging Infectious Diseases, 11, 5, pp. 702-705, (2005); 
Van Den Berg T., Lambrecht B., Marche S., Steensels M., Van Borm S., Bublot M., Influenza vaccines and vaccination strategies in birds, Comparative Immunology, Microbiology and Infectious Diseases, 31, 2-3, pp. 121-165, (2008); 
Veits J., Wiesner D., Fuchs W., Hoffmann B., Granzow H., Starick E., Mundt E., Schirrmeier H., Mebatsion T., Mettenleiter T.C., Romer-Oberdorfer A., Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza, Proceedings of the National Academy of Sciences of the United States of America, 103, 21, pp. 8197-8202, (2006)#FRF#
